SlideShare uma empresa Scribd logo
1 de 14
HEMAS HOLDINGS PLC




             Investor Presentation
                       Q3 2012/13
Sri Lanka: Macro Highlights
                                             Economic Growth
                      8.4%            8.3%
                                                      7.9%
                                                                                                    Decreased to 4.8% in Q3;
Economic Growth                                                        6.4%
                                                                                                    lowest in 3 years
                                                                                      4.8%


                    Q3 2011       Q4 2011        Q1 2012          Q2 2012            Q3 2012

                                                 12 M T Bill rate

                             11.32%
                                        12.88%        13.02%
                                                                  11.69%                            Dropped to 11.25% posting
                                                                                       11.25%
Interest Rates    9.31%                                                                             a downward trend

                    Q3 2011    Q4 2011       Q1 2012         Q2 2012     Q3 2012      Jan 2013

                                                 Exchange Rate
                               129.57        135.46      131.17         128.82        128.29        Showed a tendency of
Exchange Rate      114.88                                                                           recovering: Rs 128.29/USD

                  Dec 2011 March 2012 June 2012 Sept 2012 Dec 2012                   Jan 2013

                                                      Inflation
                                                               9.1%           9.2%           9.8%
                                               9.3%
                    4.9%         5.5%                                                               Moved upwards; YoY 9.8%
Inflation                                                                                           Annual average for 2012
                                                                                                    was recorded at 7.6%
                  Dec 2011 March 2012 June 2012 Sept 2012                 Dec 2012       Jan 2013
                                                                                                                     Source: CBSL
Hemas Group: A Snapshot

Share Price (As at 26.02.2013)                                Rs. 27.90
Market Capitalization                                         Rs. 14.4Bn
% of Total Market                                             0.65%
PER                                                           10.2*
PBV                                                           1.25
No of Shares                                                  515,290,620
Public Shareholding                                           28.33%

 PER          Sector & Market PER vs Hemas PER
30.0


25.0


20.0


15.0


10.0


 5.0


  -
       Sept 2011   Dec 2011    Mar 2012     June 2012   Sept 2012    Dec 2012

                                                                                * PER based on annualized earnings
              Diversified Sector PER      Market PER     Hemas PER
Hemas Group: Performance Highlights

Figures are in Rs. Millions   Q3 2012/13   Q3 2011/12   % Change

Group Turnover                 19,244       15,255           26%
PAT                             1,196         917            30%
Group Earnings                  1,053         837            26%
Cash from Operations             382          625           -39%
Total Assets                   24,926       20,385           22%
Shareholders’ Funds            11,540        9,549           21%
Capital Employed               18,745       15,240           23%

                              Q3 2012/13   Q3 2011/12   % Change

EPS                              2.72          2.17          26%
Net Assets per Share             22.40        18.53          21%
ROE                              13.3%        12.4%           8%
ROCE                             12.8%        11.3%          13%

                                                              All financials as per SLAS
Q3: Revenue and Earnings Highlights
Rs. Millions
20,000
                           Group Revenue                         Growth
                                                                   30%
                                                                                               Group revenue recorded a
15,000                                                             20%                          growth of 26.1%, YoY
10,000                                                             10%                         Revenue growth was driven
  5,000                                                            0%
                                                                                                by Power, Healthcare and
                                                                                                FMCG sectors
      -                                                            -10%
               2007/08 2008/09 2009/10 2010/11 2011/12 2012/13

                          Group Turnover    YoY Growth

                                                                 Rs. Millions                                                                      Growth

                                                                     1,200                         Group Earnings                                   80%

                                                                     1,000
              Group earnings recorded a                                                                                                            60%

               growth of 25.8%, YoY                                     800
                                                                                                                                                    40%
                                                                        600
              Earnings growth was driven                                                                                                           20%
                                                                        400
               by FMCG, Leisure, Healthcare                                                                                                         0%
                                                                        200
               and Transportation sectors
                                                                          -                                                                         -20%
                                                                                2007/08       2008/09   2009/10   2010/11    2011/12     2012/13
                                                                                                    Group Earnings          YoY Growth
Q3: Revenue and Earnings Contribution

Q3: Revenue Contribution                  Q3: Earnings Contribution

                 4%
                                                   11%


   23%                              29%
                                          16%                            39%


  4%
                                           7%
    6%
                              35%

                                                               27%

FMCG             Healthcare    Leisure
                                          FMCG             Healthcare   Leisure
Transportation   Power         Other
                                          Transportation   Power
FMCG: Performance Highlights
                                          Q3 12/13    Q3 11/12   Change
                     Turnover (Rs. Mn)      5,636      4,884      15%
                     PAT (Rs. Mn)           548         431       27%

   Revenue growth was driven by strong performance in personal care and personal wash
    categories led by Baby Cheramy, Kumarika and Velvet brands

   Personal care category posted the highest market share achieved over two years

   Clogard recorded the highest market share since 2008, while Kumarika recorded the
    highest market share since its introduction

   Hemas entered the deodorant market by introducing two new variants under Gold and new
    fragrances under Goya & Pro Sport, strengthening our market position in the fragrance
    category

   VAT on large scale wholesalers and supermarkets by the 2013 Budget proposal impacted
    modern trade sales
Big Heart Project continues


   Continuing the Big Heart project which was commenced to fund the educational needs of
    disadvantaged children, a 20-20 cricket match was organized and played in January 2013

   This cricket match reunited the 96 world cup champions who stepped forward as
    volunteers for this worthy cause and they played against Sri Lankan cricket legends

   Mr. Roshan Mahanama appeared as the honorary project ambassador for this project
    which was directed towards fulfilling a national need

   Funds raised from this event which was a great success, was donated to the ‘Nana Diriya’
    program of the Ministry of Child Development and Women Affairs
Healthcare: Performance Highlights
                                            Q3 12/13    Q3 11/12    Change
                      Turnover (Rs. Mn)       6,662      5,462       22%
                      PAT (Rs. Mn)            360         270        33%

   Pharmaceutical business was the main contributor to sector revenue growth
     •   Revenue growth of Pharma: 20.8%
     •   Revenue growth of Hospitals: 28.1%
   Hemas Pharmaceuticals reinforced its position as the market leader with an improved
    market share of 17.77% (Source: IMS)

   Hemas Wattala Hospital celebrated its 4th year of operations during the quarter

   Construction of our 3rd hospital at Thalawathugoda is on schedule, and we expect to serve
    our first patient in mid 2013

   Preliminary discussions were successfully concluded to introduce dialysis services in our
    hospitals with the aim of strengthening the healthcare service portfolio
Leisure: Performance Highlights
                                            Q3 12/13   Q3 11/12    Change
                      Turnover (Rs. Mn)      1,084       725        50%
                      PAT (Rs. Mn)            204         26       696%
   Strong performance of the Leisure sector was mainly driven by the hotel business which
    experienced an average occupancy over 70% resulting from an attractive winter season
   Gross operating profit of the Hotels grew by an impressive 147% over last year
   Avani Kalutara resort was officially declared open by Hon. Basil Rajapakse in November 2012
   Serendib Leisure Hotels were recognized with the following accolades during Q3:
        Avani Bentota Resort & Spa - Agoda Gold Circle Award for excellence in on-line
        distribution
        Club Hotel Dolphin - Holiday Check Award 2013 for being one of the 99 most popular
        hotels worldwide in the “Family” category
        Avani Bentota Resort & Spa and Hotel Sigiriya - Merit Certificates awarded by the EU-
        SWITCH ASIA for conservation & waste management
   Our destination management company, Diethelm Travels enjoyed a healthy quarter with
    41% increase in revenue
Transportation: Performance Highlights
                                           Q3 12/13    Q3 11/12   Change
                      Turnover (Rs. Mn)      747         541       38%
                      PAT (Rs. Mn)           217         160       36%

   Strong performance in Aviation and Maritime segments resulted 38% growth in revenue
    over the last year
   Aviation segment enjoyed a healthy quarter with outbound travel business continuing to
    increase its market share
   “MercMas”; joint venture with Mercantile Shipping which commenced its operations to
    transport crew and sea marshals continues to gain acceptance among key clients
   Feeder agency business enjoyed a good quarter serving new customers with maritime
    services, which contributed positively towards sector earnings
   Our Logistics segment expanded its service portfolio into contract warehousing apart from
    the empty container transport business
Power: Performance Highlights
                                           Q3 12/13   Q3 11/12    Change
                     Turnover (Rs. Mn)      4,395       3,119      41%
                     PAT (Rs. Mn)            212        247       -14%

   Revenue growth of the sector was mainly driven by growth of our thermal power plant
    Heladhanavi due to the pass-through effect of escalating fuel price

   Despite ‘Giddawa’ hydro power plant being affected by floods during the quarter, our hydro
    power plants recorded a revenue growth of 31.6%, led by the performance of Magal Ganga

   Hydro power segment recorded a 33% increase in energy generation headed by Magal
    Ganga plant supported by the healthy north‐east monsoonal rains

   Sector earnings reported a decline of 14% with higher costs of borrowing and exchange
    losses on foreign currency borrowings, most of which is unrealized

   Pre-development work on new projects in Sri Lanka and in the East-African region are
    expected to continue over the next quarter
Corporate Social Responsibility
   Our 36th “Piyawara” preschool was opened in Theethakarie, Mulativue in February 2013;
    this is the second community pre-school opened in Mulativue

   First model pre school in Kilinochchi is under construction and scheduled to be opened in
    March 2013




   An Angel Christmas tree was set up to collect Christmas gifts to be distributed among
    underprivileged children in Killinochchi, Ambalnagar, Mulativue, Pudukuduiruppu and
    Dharmapuram
Hemas Investor Relations:

           Telephone: +94 11 4 731 731
               Email: ir@hemas.com
           Web: http://www.hemas.com




              Hemas Holdings PLC
Hemas House, 75, Braybrooke Place, Colombo 2, Sri Lanka

Mais conteúdo relacionado

Mais procurados

Hemas Sustainability Report 201415- FINAL
Hemas Sustainability Report 201415- FINALHemas Sustainability Report 201415- FINAL
Hemas Sustainability Report 201415- FINAL
Sudashini Christopher
 

Mais procurados (20)

Hemas Holdings PLC investor presentation - Q1 2016/17
Hemas Holdings PLC investor presentation - Q1 2016/17Hemas Holdings PLC investor presentation - Q1 2016/17
Hemas Holdings PLC investor presentation - Q1 2016/17
 
Hemas Holdings PLC Investor Presentation Q3 - 2013/14
Hemas Holdings PLC Investor Presentation Q3 - 2013/14Hemas Holdings PLC Investor Presentation Q3 - 2013/14
Hemas Holdings PLC Investor Presentation Q3 - 2013/14
 
Hemas Holdings PLC Investor Presentation Q2 2018/19
Hemas Holdings PLC Investor Presentation Q2 2018/19Hemas Holdings PLC Investor Presentation Q2 2018/19
Hemas Holdings PLC Investor Presentation Q2 2018/19
 
Hemas Holdings PLC - Investor Presentation Q1 2013/14
Hemas Holdings PLC - Investor Presentation Q1 2013/14Hemas Holdings PLC - Investor Presentation Q1 2013/14
Hemas Holdings PLC - Investor Presentation Q1 2013/14
 
Hemas Holdings PLC investor presentation - Q2 2016/17
Hemas Holdings PLC investor presentation - Q2 2016/17Hemas Holdings PLC investor presentation - Q2 2016/17
Hemas Holdings PLC investor presentation - Q2 2016/17
 
Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18Hemas Holdings PLC Investor Presentation Q4 2017/18
Hemas Holdings PLC Investor Presentation Q4 2017/18
 
Hemas Holdings PLC Investor Presentation Q1 2017/18
Hemas Holdings PLC Investor Presentation Q1 2017/18 Hemas Holdings PLC Investor Presentation Q1 2017/18
Hemas Holdings PLC Investor Presentation Q1 2017/18
 
Hemas Holdings PLC Investor Presentation Q1 2018/19
Hemas Holdings PLC Investor Presentation Q1 2018/19Hemas Holdings PLC Investor Presentation Q1 2018/19
Hemas Holdings PLC Investor Presentation Q1 2018/19
 
Brief recording
Brief recordingBrief recording
Brief recording
 
Hemas Sustainability Report 201415- FINAL
Hemas Sustainability Report 201415- FINALHemas Sustainability Report 201415- FINAL
Hemas Sustainability Report 201415- FINAL
 
Hemas Holdings PLC Investor Presentation Q3 2018/19
Hemas Holdings PLC Investor Presentation Q3 2018/19Hemas Holdings PLC Investor Presentation Q3 2018/19
Hemas Holdings PLC Investor Presentation Q3 2018/19
 
Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17Hemas Holdings PLC Investor Presentation Q3 2016-17
Hemas Holdings PLC Investor Presentation Q3 2016-17
 
KMLOONG – Fundamental Analysis FY15
KMLOONG – Fundamental Analysis FY15KMLOONG – Fundamental Analysis FY15
KMLOONG – Fundamental Analysis FY15
 
Hemas Holdings PLC Investor Presentation Q3 2017/18
Hemas Holdings PLC Investor Presentation Q3 2017/18Hemas Holdings PLC Investor Presentation Q3 2017/18
Hemas Holdings PLC Investor Presentation Q3 2017/18
 
Bursa – Fundamental Analysis FY15
Bursa – Fundamental Analysis FY15Bursa – Fundamental Analysis FY15
Bursa – Fundamental Analysis FY15
 
PADINI – Fundamental Analysis FY15
PADINI – Fundamental Analysis FY15PADINI – Fundamental Analysis FY15
PADINI – Fundamental Analysis FY15
 
Tenaga – Fundamental Analysis FY15
Tenaga – Fundamental Analysis FY15Tenaga – Fundamental Analysis FY15
Tenaga – Fundamental Analysis FY15
 
GAB – Fundamental Analysis FY15
GAB – Fundamental Analysis FY15GAB – Fundamental Analysis FY15
GAB – Fundamental Analysis FY15
 
DIGI – Fundamental Analysis FY15
DIGI – Fundamental Analysis FY15DIGI – Fundamental Analysis FY15
DIGI – Fundamental Analysis FY15
 
CARLSBG – Fundamental Analysis FY14
CARLSBG – Fundamental Analysis FY14CARLSBG – Fundamental Analysis FY14
CARLSBG – Fundamental Analysis FY14
 

Semelhante a Investor Presentation Q3 2012/13

Korea Fund, Inc. Second Quarter 2012
Korea Fund, Inc. Second Quarter 2012Korea Fund, Inc. Second Quarter 2012
Korea Fund, Inc. Second Quarter 2012
Company Spotlight
 
Profarma 4 q12
Profarma 4 q12Profarma 4 q12
Profarma 4 q12
Profarma
 
4Q 2012 Earnings Presentation
4Q 2012 Earnings Presentation4Q 2012 Earnings Presentation
4Q 2012 Earnings Presentation
irbgcpartners
 
Mukesh agwl
Mukesh agwlMukesh agwl
Mukesh agwl
AIPMA
 
Apl investor presentation may 2012 final version
Apl investor presentation may 2012 final versionApl investor presentation may 2012 final version
Apl investor presentation may 2012 final version
Parish Aggarwal
 
Third Quarter Results FY 2010-11:Investor Release
Third Quarter Results FY 2010-11:Investor Release Third Quarter Results FY 2010-11:Investor Release
Third Quarter Results FY 2010-11:Investor Release
Semalytix
 
Hclt q3-2011-jfm'11-ir release
Hclt q3-2011-jfm'11-ir releaseHclt q3-2011-jfm'11-ir release
Hclt q3-2011-jfm'11-ir release
anvithanet
 
Abch results presentation 2012
Abch results presentation 2012Abch results presentation 2012
Abch results presentation 2012
wgjlubbe
 
2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng
Hyundai Finance
 
2011 Half Year Results Presentation
2011 Half Year Results Presentation2011 Half Year Results Presentation
2011 Half Year Results Presentation
SGS
 
emerson electricl annual reports 2008
emerson electricl annual reports 2008emerson electricl annual reports 2008
emerson electricl annual reports 2008
finance12
 

Semelhante a Investor Presentation Q3 2012/13 (20)

Korea Fund, Inc. Second Quarter 2012
Korea Fund, Inc. Second Quarter 2012Korea Fund, Inc. Second Quarter 2012
Korea Fund, Inc. Second Quarter 2012
 
Profarma 4 q12
Profarma 4 q12Profarma 4 q12
Profarma 4 q12
 
4Q 2012 Earnings Presentation
4Q 2012 Earnings Presentation4Q 2012 Earnings Presentation
4Q 2012 Earnings Presentation
 
Mukesh agwl
Mukesh agwlMukesh agwl
Mukesh agwl
 
Apl investor presentation may 2012 final version
Apl investor presentation may 2012 final versionApl investor presentation may 2012 final version
Apl investor presentation may 2012 final version
 
Third Quarter Results FY 2010-11:Investor Release
Third Quarter Results FY 2010-11:Investor Release Third Quarter Results FY 2010-11:Investor Release
Third Quarter Results FY 2010-11:Investor Release
 
Hclt q3-2011-jfm'11-ir release
Hclt q3-2011-jfm'11-ir releaseHclt q3-2011-jfm'11-ir release
Hclt q3-2011-jfm'11-ir release
 
2012 Financial Results
2012 Financial Results2012 Financial Results
2012 Financial Results
 
Abch results presentation 2012
Abch results presentation 2012Abch results presentation 2012
Abch results presentation 2012
 
Feb 20 2012 - Nestlé 2011 Full-year roadshow presentation
Feb 20 2012 - Nestlé 2011 Full-year roadshow presentationFeb 20 2012 - Nestlé 2011 Full-year roadshow presentation
Feb 20 2012 - Nestlé 2011 Full-year roadshow presentation
 
2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng
 
Danone sales q3 2012
Danone sales q3 2012  Danone sales q3 2012
Danone sales q3 2012
 
4Q 2011 Conference Call Feb 16 2012
4Q 2011 Conference Call Feb 16 20124Q 2011 Conference Call Feb 16 2012
4Q 2011 Conference Call Feb 16 2012
 
Study of Debit, Credit & Prepaid Programs. Member Preferences and Marketing S...
Study of Debit, Credit & Prepaid Programs. Member Preferences and Marketing S...Study of Debit, Credit & Prepaid Programs. Member Preferences and Marketing S...
Study of Debit, Credit & Prepaid Programs. Member Preferences and Marketing S...
 
2011 Half Year Results Presentation
2011 Half Year Results Presentation2011 Half Year Results Presentation
2011 Half Year Results Presentation
 
WEG Q3 2012 Conference Call
WEG Q3 2012 Conference CallWEG Q3 2012 Conference Call
WEG Q3 2012 Conference Call
 
Korea fund4q presentation
Korea fund4q presentationKorea fund4q presentation
Korea fund4q presentation
 
Korea Supplement
Korea SupplementKorea Supplement
Korea Supplement
 
emerson electricl annual reports 2008
emerson electricl annual reports 2008emerson electricl annual reports 2008
emerson electricl annual reports 2008
 
Nielsen grocery report 2012
Nielsen grocery report 2012Nielsen grocery report 2012
Nielsen grocery report 2012
 

Investor Presentation Q3 2012/13

  • 1. HEMAS HOLDINGS PLC Investor Presentation Q3 2012/13
  • 2. Sri Lanka: Macro Highlights Economic Growth 8.4% 8.3% 7.9% Decreased to 4.8% in Q3; Economic Growth 6.4% lowest in 3 years 4.8% Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 12 M T Bill rate 11.32% 12.88% 13.02% 11.69% Dropped to 11.25% posting 11.25% Interest Rates 9.31% a downward trend Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Jan 2013 Exchange Rate 129.57 135.46 131.17 128.82 128.29 Showed a tendency of Exchange Rate 114.88 recovering: Rs 128.29/USD Dec 2011 March 2012 June 2012 Sept 2012 Dec 2012 Jan 2013 Inflation 9.1% 9.2% 9.8% 9.3% 4.9% 5.5% Moved upwards; YoY 9.8% Inflation Annual average for 2012 was recorded at 7.6% Dec 2011 March 2012 June 2012 Sept 2012 Dec 2012 Jan 2013 Source: CBSL
  • 3. Hemas Group: A Snapshot Share Price (As at 26.02.2013) Rs. 27.90 Market Capitalization Rs. 14.4Bn % of Total Market 0.65% PER 10.2* PBV 1.25 No of Shares 515,290,620 Public Shareholding 28.33% PER Sector & Market PER vs Hemas PER 30.0 25.0 20.0 15.0 10.0 5.0 - Sept 2011 Dec 2011 Mar 2012 June 2012 Sept 2012 Dec 2012 * PER based on annualized earnings Diversified Sector PER Market PER Hemas PER
  • 4. Hemas Group: Performance Highlights Figures are in Rs. Millions Q3 2012/13 Q3 2011/12 % Change Group Turnover 19,244 15,255 26% PAT 1,196 917 30% Group Earnings 1,053 837 26% Cash from Operations 382 625 -39% Total Assets 24,926 20,385 22% Shareholders’ Funds 11,540 9,549 21% Capital Employed 18,745 15,240 23% Q3 2012/13 Q3 2011/12 % Change EPS 2.72 2.17 26% Net Assets per Share 22.40 18.53 21% ROE 13.3% 12.4% 8% ROCE 12.8% 11.3% 13% All financials as per SLAS
  • 5. Q3: Revenue and Earnings Highlights Rs. Millions 20,000 Group Revenue Growth 30%  Group revenue recorded a 15,000 20% growth of 26.1%, YoY 10,000 10%  Revenue growth was driven 5,000 0% by Power, Healthcare and FMCG sectors - -10% 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13 Group Turnover YoY Growth Rs. Millions Growth 1,200 Group Earnings 80% 1,000  Group earnings recorded a 60% growth of 25.8%, YoY 800 40% 600  Earnings growth was driven 20% 400 by FMCG, Leisure, Healthcare 0% 200 and Transportation sectors - -20% 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13 Group Earnings YoY Growth
  • 6. Q3: Revenue and Earnings Contribution Q3: Revenue Contribution Q3: Earnings Contribution 4% 11% 23% 29% 16% 39% 4% 7% 6% 35% 27% FMCG Healthcare Leisure FMCG Healthcare Leisure Transportation Power Other Transportation Power
  • 7. FMCG: Performance Highlights Q3 12/13 Q3 11/12 Change Turnover (Rs. Mn) 5,636 4,884 15% PAT (Rs. Mn) 548 431 27%  Revenue growth was driven by strong performance in personal care and personal wash categories led by Baby Cheramy, Kumarika and Velvet brands  Personal care category posted the highest market share achieved over two years  Clogard recorded the highest market share since 2008, while Kumarika recorded the highest market share since its introduction  Hemas entered the deodorant market by introducing two new variants under Gold and new fragrances under Goya & Pro Sport, strengthening our market position in the fragrance category  VAT on large scale wholesalers and supermarkets by the 2013 Budget proposal impacted modern trade sales
  • 8. Big Heart Project continues  Continuing the Big Heart project which was commenced to fund the educational needs of disadvantaged children, a 20-20 cricket match was organized and played in January 2013  This cricket match reunited the 96 world cup champions who stepped forward as volunteers for this worthy cause and they played against Sri Lankan cricket legends  Mr. Roshan Mahanama appeared as the honorary project ambassador for this project which was directed towards fulfilling a national need  Funds raised from this event which was a great success, was donated to the ‘Nana Diriya’ program of the Ministry of Child Development and Women Affairs
  • 9. Healthcare: Performance Highlights Q3 12/13 Q3 11/12 Change Turnover (Rs. Mn) 6,662 5,462 22% PAT (Rs. Mn) 360 270 33%  Pharmaceutical business was the main contributor to sector revenue growth • Revenue growth of Pharma: 20.8% • Revenue growth of Hospitals: 28.1%  Hemas Pharmaceuticals reinforced its position as the market leader with an improved market share of 17.77% (Source: IMS)  Hemas Wattala Hospital celebrated its 4th year of operations during the quarter  Construction of our 3rd hospital at Thalawathugoda is on schedule, and we expect to serve our first patient in mid 2013  Preliminary discussions were successfully concluded to introduce dialysis services in our hospitals with the aim of strengthening the healthcare service portfolio
  • 10. Leisure: Performance Highlights Q3 12/13 Q3 11/12 Change Turnover (Rs. Mn) 1,084 725 50% PAT (Rs. Mn) 204 26 696%  Strong performance of the Leisure sector was mainly driven by the hotel business which experienced an average occupancy over 70% resulting from an attractive winter season  Gross operating profit of the Hotels grew by an impressive 147% over last year  Avani Kalutara resort was officially declared open by Hon. Basil Rajapakse in November 2012  Serendib Leisure Hotels were recognized with the following accolades during Q3: Avani Bentota Resort & Spa - Agoda Gold Circle Award for excellence in on-line distribution Club Hotel Dolphin - Holiday Check Award 2013 for being one of the 99 most popular hotels worldwide in the “Family” category Avani Bentota Resort & Spa and Hotel Sigiriya - Merit Certificates awarded by the EU- SWITCH ASIA for conservation & waste management  Our destination management company, Diethelm Travels enjoyed a healthy quarter with 41% increase in revenue
  • 11. Transportation: Performance Highlights Q3 12/13 Q3 11/12 Change Turnover (Rs. Mn) 747 541 38% PAT (Rs. Mn) 217 160 36%  Strong performance in Aviation and Maritime segments resulted 38% growth in revenue over the last year  Aviation segment enjoyed a healthy quarter with outbound travel business continuing to increase its market share  “MercMas”; joint venture with Mercantile Shipping which commenced its operations to transport crew and sea marshals continues to gain acceptance among key clients  Feeder agency business enjoyed a good quarter serving new customers with maritime services, which contributed positively towards sector earnings  Our Logistics segment expanded its service portfolio into contract warehousing apart from the empty container transport business
  • 12. Power: Performance Highlights Q3 12/13 Q3 11/12 Change Turnover (Rs. Mn) 4,395 3,119 41% PAT (Rs. Mn) 212 247 -14%  Revenue growth of the sector was mainly driven by growth of our thermal power plant Heladhanavi due to the pass-through effect of escalating fuel price  Despite ‘Giddawa’ hydro power plant being affected by floods during the quarter, our hydro power plants recorded a revenue growth of 31.6%, led by the performance of Magal Ganga  Hydro power segment recorded a 33% increase in energy generation headed by Magal Ganga plant supported by the healthy north‐east monsoonal rains  Sector earnings reported a decline of 14% with higher costs of borrowing and exchange losses on foreign currency borrowings, most of which is unrealized  Pre-development work on new projects in Sri Lanka and in the East-African region are expected to continue over the next quarter
  • 13. Corporate Social Responsibility  Our 36th “Piyawara” preschool was opened in Theethakarie, Mulativue in February 2013; this is the second community pre-school opened in Mulativue  First model pre school in Kilinochchi is under construction and scheduled to be opened in March 2013  An Angel Christmas tree was set up to collect Christmas gifts to be distributed among underprivileged children in Killinochchi, Ambalnagar, Mulativue, Pudukuduiruppu and Dharmapuram
  • 14. Hemas Investor Relations: Telephone: +94 11 4 731 731 Email: ir@hemas.com Web: http://www.hemas.com Hemas Holdings PLC Hemas House, 75, Braybrooke Place, Colombo 2, Sri Lanka